The National Stock Exchange of India (NSE) is preparing for an IPO in September 2026, involving an Offer for Sale of up to 14.89 crore shares. To enhance liquidity, the exchange is exploring a strategy to trade its shares on its own platform under a 'permitted to trade' category. This proposal currently faces critical regulatory review by SEBI due to potential conflict-of-interest concerns.
The National Stock Exchange of India (NSE) is moving toward its highly anticipated initial public offering (IPO), which is expected to launch in the second half of September 2026. The exchange has already received a No-Objection Certificate from the Securities and Exchange Board of India (SEBI). The IPO will be an Offer for Sale (OFS) of up to 14.89 crore shares, with market estimates valuing the exchange between ₹5.2 lakh crore and ₹5.3 lakh crore.
As part of its listing strategy, the NSE is proposing a dual-venue structure. It plans to list formally on its rival, the Bombay Stock Exchange (BSE), while simultaneously allowing its shares to be traded on the NSE platform under a 'permitted to trade' category. This status would allow the shares to be accessible to investors on the NSE platform without the company being formally listed on the exchange.
The core challenge for this proposal is the regulatory framework surrounding market infrastructure institutions. Because the NSE acts as a self-regulatory organization, permitting it to list and trade on its own platform creates a potential conflict of interest. Regulations in India generally prohibit stock exchanges from self-listing to ensure that the exchange can supervise itself without bias. For the NSE to proceed with this plan, it must secure specific approval from SEBI and likely implement a new independent monitoring framework to address these governance concerns.
The primary incentive for seeking this 'permitted to trade' status is to increase liquidity for the stock and potentially qualify the shares for inclusion in benchmark indices, such as the Nifty. NSE revised its index eligibility rules in 2019 to allow securities in this category to be considered for inclusion, provided they meet necessary disclosure obligations. There are currently around 250 companies, including entities like Elantas Beck India, Goodyear India, and Novartis India, that trade on the NSE under this status despite not being formally listed.
The final approval for this structure remains the most significant hurdle for the NSE. While the exchange has successfully resolved previous pending cases with the regulator, the unique nature of this self-trading request requires careful evaluation. Investors and market participants will likely monitor the final prospectus and SEBI's response, as these will determine whether the exchange can move forward with this dual-platform strategy or if it must limit its trading activity to the BSE.